{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:19:22Z","timestamp":1785320362409,"version":"3.55.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004530","name":"Universiti Putra Malaysia","doi-asserted-by":"crossref","award":["UPM\/800-3\/3\/1\/GPB\/9657600"],"award-info":[{"award-number":["UPM\/800-3\/3\/1\/GPB\/9657600"]}],"id":[{"id":"10.13039\/501100004530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-66601-0","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T11:02:04Z","timestamp":1722423724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Oral and topical administration of a geranyl acetophenone attenuates DNCB-induced atopic dermatitis-like skin lesions in BALB\/c mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Vivi Nur Khalieda","family":"Mohd Kasim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Zhao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikmal Hisyam","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Khairi","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daud Ahmad","family":"Israf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khozirah","family":"Shaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Tatt","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau Ling","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"66601_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S St\u00e4nder","year":"2021","unstructured":"St\u00e4nder, S. Atopic dermatitis. N. Engl. J. Med. 384, 1136\u20131143 (2021).","journal-title":"N. Engl. J. Med."},{"key":"66601_CR2","first-page":"936","volume":"11","author":"HA Hadi","year":"2021","unstructured":"Hadi, H. A. et al. The epidemiology and global burden of atopic dermatitis: A narrative review. Life Basel Switz. 11, 936 (2021).","journal-title":"Life Basel Switz."},{"key":"66601_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jdin.2020.10.002","volume":"2","author":"K Urban","year":"2021","unstructured":"Urban, K. et al. The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017. JAAD Int. 2, 12\u201318 (2021).","journal-title":"JAAD Int."},{"key":"66601_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S2213-2600(13)70277-7","volume":"2","author":"M Pinart","year":"2014","unstructured":"Pinart, M. et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: A population-based cohort study. Lancet Respir. Med. 2, 131\u2013140 (2014).","journal-title":"Lancet Respir. Med."},{"key":"66601_CR5","first-page":"202","volume":"5","author":"SK Bantz","year":"2014","unstructured":"Bantz, S. K., Zhu, Z. & Zheng, T. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell Immunol. 5, 202 (2014).","journal-title":"J. Clin. Cell Immunol."},{"key":"66601_CR6","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2018.8.e41","volume":"8","author":"S Chow","year":"2018","unstructured":"Chow, S. et al. A clinician\u2019s reference guide for the management of atopic dermatitis in Asians. Asia Pac. Allergy 8, e41. https:\/\/doi.org\/10.5415\/apallergy.2018.8.e41 (2018).","journal-title":"Asia Pac. Allergy"},{"key":"66601_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd012119.pub2","volume":"2","author":"EJ Zuuren","year":"2017","unstructured":"Zuuren, E. J., Fedorowicz, Z., Christensen, R., Lavrijsen, A. P. & Arents, B. W. Emollients and moisturisers for eczema. Cochrane Database Syst. Rev. 2, CD12119. https:\/\/doi.org\/10.1002\/14651858.cd012119.pub2 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"66601_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjd.15928","volume":"178","author":"AM Drucker","year":"2018","unstructured":"Drucker, A. M. et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br. J. Dermatol. 178, 768 (2018).","journal-title":"Br. J. Dermatol."},{"key":"66601_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13555-016-0167-9","volume":"7","author":"CEM Griffiths","year":"2017","unstructured":"Griffiths, C. E. M., van de Kerkhof, P. & Czarnecka-Operacz, M. Psoriasis and atopic dermatitis. Dermatol. Ther. 7, 31\u201341 (2017).","journal-title":"Dermatol. Ther."},{"key":"66601_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/exd.13421","volume":"27","author":"H Choi","year":"2018","unstructured":"Choi, H. et al. Manifestation of atopic dermatitis-like skin in TNCB-induced NC\/Nga mice is ameliorated by topical treatment of substance P, possibly through blockade of allergic inflammation. Exp. Dermatol. 27, 396\u2013402 (2018).","journal-title":"Exp. Dermatol."},{"key":"66601_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaip.2012.09.002","volume":"1","author":"PD Arkwright","year":"2013","unstructured":"Arkwright, P. D. et al. Management of difficult-to-treat atopic dermatitis. J. Allergy Clin. Immunol. Pract. 1, 142\u2013151 (2013).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"66601_CR12","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1016\/j.bmc.2011.09.001","volume":"19","author":"K Shaari","year":"2011","unstructured":"Shaari, K. et al. Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase. Bioorg. Med. Chem. 19, 6340\u20136347 (2011).","journal-title":"Bioorg. Med. Chem."},{"key":"66601_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.736339","volume":"12","author":"YH Chan","year":"2021","unstructured":"Chan, Y. H. et al. Pharmacological properties of 2,4,6-trihydroxy-3-geranyl acetophenone and the underlying signaling pathways: Progress and prospects. Front. Pharmacol. 12, 736339. https:\/\/doi.org\/10.3389\/fphar.2021.736339 (2021).","journal-title":"Front. Pharmacol."},{"key":"66601_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.taap.2012.01.003","volume":"259","author":"N Ismail","year":"2012","unstructured":"Ismail, N. et al. A geranyl acetophenone targeting cysteinyl leukotriene synthesis prevents allergic airway inflammation in ovalbumin-sensitized mice. Toxicol. Appl. Pharmacol. 259, 257\u2013262 (2012).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"66601_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.taap.2017.02.002","volume":"319","author":"JW Tan","year":"2017","unstructured":"Tan, J. W. et al. Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis. Toxicol. Appl. Pharmacol. 319, 47\u201358 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"66601_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bcp.2017.08.010","volume":"144","author":"JW Tan","year":"2017","unstructured":"Tan, J. W. et al. LAT is essential for the mast cell stabilising effect of tHGA in IgE-mediated mast cell activation. Biochem. Pharmacol. 144, 132\u2013148 (2017).","journal-title":"Biochem. Pharmacol."},{"key":"66601_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250359","volume":"53","author":"YH Keith","year":"2023","unstructured":"Keith, Y. H., Egawa, G., Honda, T. & Kabashima, K. Mast cells in type 2 skin inflammation: Maintenance and function. Eur. J. Immunol. 53, 2250359. https:\/\/doi.org\/10.1002\/eji.202250359 (2023).","journal-title":"Eur. J. Immunol."},{"key":"66601_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2017.01.011","volume":"797","author":"YZ Lee","year":"2017","unstructured":"Lee, Y. Z. et al. An orally active geranyl acetophenone attenuates airway remodeling in a murine model of chronic asthma. Eur. J. Pharmacol. 797, 53\u201364 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"66601_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2215356","volume":"34","author":"K Myers","year":"2023","unstructured":"Myers, K. et al. Treatment preferences among patients with mild-to-moderate atopic dermatitis. J. Dermatol. Treat. 34, 2215356. https:\/\/doi.org\/10.1080\/09546634.2023.2215356 (2023).","journal-title":"J. Dermatol. Treat."},{"key":"66601_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13555-016-0170-1","volume":"7","author":"M Megna","year":"2016","unstructured":"Megna, M. et al. Systemic treatment of adult atopic dermatitis: A review. Dermatol. Ther. 7, 1\u201323 (2016).","journal-title":"Dermatol. Ther."},{"key":"66601_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fphar.2017.00837","volume":"8","author":"YZ Lee","year":"2017","unstructured":"Lee, Y. Z. et al. Blockade of eosinophil-induced bronchial epithelial\u2013mesenchymal transition with a geranyl acetophenone in a coculture model. Front. Pharmacol. 8, 837 (2017).","journal-title":"Front. Pharmacol."},{"key":"66601_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34847-0","volume":"8","author":"HM Yap","year":"2018","unstructured":"Yap, H. M. et al. The geranyl acetophenone tHGA attenuates human bronchial smooth muscle proliferation via inhibition of AKT phosphorylation. Sci. Rep. 8, 16640. https:\/\/doi.org\/10.1038\/s41598-018-34847-0 (2018).","journal-title":"Sci. Rep."},{"key":"66601_CR23","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals, 8th edn. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK54050\/ (National Academies Press, 2011)."},{"key":"66601_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12917-020-02451-y","volume":"16","author":"NP Sert","year":"2020","unstructured":"Sert, N. P. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. BMC Vet. Res. 16, 242 (2020).","journal-title":"BMC Vet. Res."},{"key":"66601_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jdermsci.2015.06.005","volume":"79","author":"M Jung","year":"2015","unstructured":"Jung, M. et al. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-\u03baB and STAT activation. J. Dermatol. Sci. 79, 252\u2013261 (2015).","journal-title":"J. Dermatol. Sci."},{"key":"66601_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jdermsci.2018.06.002","volume":"91","author":"YY Choi","year":"2018","unstructured":"Choi, Y. Y., Kim, M. H., Lee, H., Jo, S. Y. & Yang, W. M. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model. J. Dermatol. Sci. 91, 292\u2013300 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"66601_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12906-017-1584-8","volume":"17","author":"JM Ku","year":"2017","unstructured":"Ku, J. M. et al. Effects of Angelicae dahuricae radix on 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice model. BMC Complement. Altern. Med. 17, 98 (2017).","journal-title":"BMC Complement. Altern. Med."},{"key":"66601_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","volume":"24","author":"WN Arifin","year":"2017","unstructured":"Arifin, W. N. & Zahiruddin, W. M. Sample size calculation in animal studies using resource equation approach. Malays. J. Med. Sci. 24, 101\u2013105 (2017).","journal-title":"Malays. J. Med. Sci."},{"key":"66601_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1166\/jbn.2012.1445","volume":"8","author":"D Lococo","year":"2012","unstructured":"Lococo, D., Mora-Huertas, C. E., Fessi, H., Zaanoun, I. & Elaissari, A. Argan oil nanoemulsions as new hydrophobic drug-loaded delivery system for transdermal application. J. Biomed. Nanotechnol. 8, 843\u2013848 (2012).","journal-title":"J. Biomed. Nanotechnol."},{"key":"66601_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0923-1811(02)00070-1","volume":"30","author":"I Hikita","year":"2002","unstructured":"Hikita, I. et al. Characterization of dermatitis arising spontaneously in DS-Nh mice maintained under conventional conditions: Another possible model for atopic dermatitis. J. Dermatol. Sci. 30, 142\u2013153 (2002).","journal-title":"J. Dermatol. Sci."},{"key":"66601_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","volume":"84","author":"S Weidinger","year":"2018","unstructured":"Weidinger, S., Beck, L. A., Bieber, T., Kabashima, K. & Irvine, A. D. Atopic dermatitis. Nat. Rev. Dis. Primer 84, 1\u201320 (2018).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"66601_CR32","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/bjd.19457","volume":"184","author":"JI Silverberg","year":"2021","unstructured":"Silverberg, J. I. et al. What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study. Br. J. Dermatol. 184, 888\u2013895 (2021).","journal-title":"Br. J. Dermatol."},{"key":"66601_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fmed.2017.00119","volume":"4","author":"E De Vuyst","year":"2017","unstructured":"De Vuyst, E., Salmon, M., Evrard, C., Lambert de Rouvroit, C. & Poumay, Y. Atopic dermatitis studies through in vitro models. Front. Med. 4, 119. https:\/\/doi.org\/10.3389\/fmed.2017.00119 (2017).","journal-title":"Front. Med."},{"key":"66601_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/jid.2008.106","volume":"129","author":"H Jin","year":"2009","unstructured":"Jin, H., He, R., Oyoshi, M. & Geha, R. S. Animal models of atopic dermatitis. J. Investig. Dermatol. 129, 31\u201340 (2009).","journal-title":"J. Investig. Dermatol."},{"key":"66601_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0167-5699(97)01186-9","volume":"19","author":"S Grabbe","year":"1998","unstructured":"Grabbe, S. & Schwarz, T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19, 37\u201344 (1998).","journal-title":"Immunol. Today"},{"key":"66601_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/10799900252952181","volume":"22","author":"H Watanabe","year":"2002","unstructured":"Watanabe, H., Unger, M., Tuvel, B., Wang, B. & Sauder, D. N. Contact hypersensitivity: The mechanism of immune responses and T cell balance. J. Interferon Cytokine Res. Off J. Int. Soc. Interferon Cytokine Res. 22, 407\u2013412 (2002).","journal-title":"J. Interferon Cytokine Res. Off J. Int. Soc. Interferon Cytokine Res."},{"key":"66601_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4172\/2155-9899.1000110","volume":"2","author":"EB Brandt","year":"2011","unstructured":"Brandt, E. B. & Sivaprasad, U. Th2 cytokines and atopic dermatitis. J. Clin. Cell Immunol. 2, 110 (2011).","journal-title":"J. Clin. Cell Immunol."},{"key":"66601_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/ITT.S260370","volume":"9","author":"A Chiricozzi","year":"2020","unstructured":"Chiricozzi, A., Maurelli, M., Peris, K. & Girolomoni, G. Targeting IL-4 for the treatment of atopic dermatitis. ImmunoTargets Ther. 9, 151\u2013156 (2020).","journal-title":"ImmunoTargets Ther."},{"key":"66601_CR39","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/intimm\/dxh117","volume":"16","author":"GR Lee","year":"2004","unstructured":"Lee, G. R. & Flavell, R. A. Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma. Int. Immunol. 16, 1155\u20131160 (2004).","journal-title":"Int. Immunol."},{"key":"66601_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1172\/JCI5669","volume":"103","author":"JM Spergel","year":"1999","unstructured":"Spergel, J. M., Mizoguchi, E., Oettgen, H., Bhan, A. K. & Geha, R. S. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Investig. 103, 1103\u20131111 (1999).","journal-title":"J. Clin. Investig."},{"key":"66601_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00281-021-00868-7","volume":"43","author":"S Radonjic-Hoesli","year":"2021","unstructured":"Radonjic-Hoesli, S., Br\u00fcggen, M.-C., Feldmeyer, L., Simon, H.-U. & Simon, D. Eosinophils in skin diseases. Semin. Immunopathol. 43, 393\u2013409 (2021).","journal-title":"Semin. Immunopathol."},{"key":"66601_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.21037\/atm-22-99","volume":"10","author":"T Wu","year":"2022","unstructured":"Wu, T., Tang, L., Feng, Y., Jia, Y. & Li, F. Eosinophils and associated parameters in different types of skin diseases related to elevated eosinophil levels. Ann. Transl. Med. 10, 73 (2022).","journal-title":"Ann. Transl. Med."},{"key":"66601_CR43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1398-9995.2004.00476.x","volume":"59","author":"D Simon","year":"2004","unstructured":"Simon, D., Braathen, L. R. & Simon, H.-U. Eosinophils and atopic dermatitis. Allergy 59, 561\u2013570 (2004).","journal-title":"Allergy"},{"key":"66601_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0952-7915(99)80010-7","volume":"11","author":"SJ Galli","year":"1999","unstructured":"Galli, S. J., Maurer, M. & Lantz, C. S. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 11, 53\u201359 (1999).","journal-title":"Curr. Opin. Immunol."},{"key":"66601_CR45","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","volume":"21","author":"T Kawakami","year":"2009","unstructured":"Kawakami, T., Ando, T., Kimura, M., Wilson, B. S. & Kawakami, Y. Mast cells in atopic dermatitis. Curr. Opin. Immunol. 21, 666\u2013678 (2009).","journal-title":"Curr. Opin. Immunol."},{"key":"66601_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/09540105.2016.1183598","volume":"27","author":"J Vaneckova","year":"2016","unstructured":"Vaneckova, J. & Buka\u010d, J. The severity of atopic dermatitis and the relation to the level of total IgE, onset of atopic dermatitis and family history about atopy. Food Agric. Immunol. 27, 734\u2013741 (2016).","journal-title":"Food Agric. Immunol."},{"key":"66601_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2005.12.045","volume":"55","author":"PG Vigo","year":"2006","unstructured":"Vigo, P. G. et al. Efficacy of anti-IgE therapy in patients with atopic dermatitis. J. Am. Acad. Dermatol. 55, 168\u2013170 (2006).","journal-title":"J. Am. Acad. Dermatol."},{"key":"66601_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.12138","volume":"170","author":"DF Finn","year":"2013","unstructured":"Finn, D. F. & Walsh, J. J. Twenty-first century mast cell stabilizers. Br. J. Pharmacol. 170, 23\u201337 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"66601_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10792-004-1818-x","volume":"25","author":"JI McGill","year":"2004","unstructured":"McGill, J. I. A review of the use of olopatadine in allergic conjunctivitis. Int. Ophthalmol. 25, 171\u2013179 (2004).","journal-title":"Int. Ophthalmol."},{"key":"66601_CR50","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.4049\/jimmunol.135.4.2719","volume":"135","author":"JL Robin","year":"1985","unstructured":"Robin, J. L., Seldin, D. C., Austen, K. F. & Lewis, R. A. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J. Immunol. 135, 2719\u20132726 (1985).","journal-title":"J. Immunol."},{"key":"66601_CR51","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/intimm\/13.7.843","volume":"13","author":"M Yamaguchi","year":"2001","unstructured":"Yamaguchi, M. et al. Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone. Int. Immunol. 13, 843\u2013851 (2001).","journal-title":"Int. Immunol."},{"key":"66601_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5089-7","volume-title":"Oxygen Transport to Tissue: Pharmacology, Mathematical Studies, and Neonatology","author":"DF Bruley","year":"1973","unstructured":"Bruley, D. F. & Bicher, H. I. Oxygen Transport to Tissue: Pharmacology, Mathematical Studies, and Neonatology (Springer, 1973). https:\/\/doi.org\/10.1007\/978-1-4684-5089-7."},{"key":"66601_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22270\/ujpr.v2i2.RW1","volume":"2","author":"AGA Al-kaf","year":"2017","unstructured":"Al-kaf, A. G. A. & Othman, A. M. A review on needle free injections. Univers. J. Pharm. Res. 2, 1\u20135 (2017).","journal-title":"Univers. J. Pharm. Res."},{"key":"66601_CR54","first-page":"1","volume":"40","author":"SA Mohamed","year":"2022","unstructured":"Mohamed, S. A. & Hargest, R. Surgical anatomy of the skin. Surg. Oxf. 40, 1\u20137 (2022).","journal-title":"Surg. Oxf."},{"key":"66601_CR55","doi-asserted-by":"publisher","DOI":"10.5772\/59929","author":"S Kok-Yong","year":"2015","unstructured":"Kok-Yong, S. & Lawrence, L. Drug distribution and drug elimination in basic pharmacokinetic concepts and some clinical applications. IntechOpen https:\/\/doi.org\/10.5772\/59929 (2015).","journal-title":"IntechOpen"},{"key":"66601_CR56","doi-asserted-by":"publisher","first-page":"11645","DOI":"10.3390\/molecules190811645","volume":"19","author":"CH Ng","year":"2014","unstructured":"Ng, C. H. et al. Synthesis and docking studies of 2,4,6-trihydroxy-3-geranylacetophenone analogs as potential lipoxygenase inhibitor. Molecules 19, 11645\u201311659 (2014).","journal-title":"Molecules"},{"key":"66601_CR57","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1517\/13543770902916614","volume":"19","author":"IP Singh","year":"2009","unstructured":"Singh, I. P., Sidana, J., Bansal, P. & Foley, W. J. Phloroglucinol compounds of therapeutic interest: Global patent and technology status. Expert Opin. Ther. Pat. 19, 847\u2013866 (2009).","journal-title":"Expert Opin. Ther. Pat."},{"key":"66601_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/14786410500045655","volume":"20","author":"K Shaari","year":"2006","unstructured":"Shaari, K., Safri, S., Abas, F., Lajis, N. H. & Israf, D. A. A geranylacetophenone from the leaves of Melicope ptelefolia. Nat. Prod. Res. 20, 415\u2013419 (2006).","journal-title":"Nat. Prod. Res."},{"key":"66601_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jep.2013.11.005","volume":"151","author":"D Antunes Viegas","year":"2014","unstructured":"Antunes Viegas, D., Palmeira-de-Oliveira, A., Salgueiro, L., Martinez-de-Oliveira, J. & Palmeira-de-Oliveira, R. Helichrysum italicum: From traditional use to scientific data. J. Ethnopharmacol. 151, 54\u201365 (2014).","journal-title":"J. Ethnopharmacol."},{"key":"66601_CR60","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jid.2016.03.019","volume":"136","author":"S Sehra","year":"2016","unstructured":"Sehra, S., Serezani, A. P. M., Oca\u00f1a, J. A., Travers, J. B. & Kaplan, M. H. Mast cells regulate epidermal barrier function and the development of allergic skin inflammation. J. Investig. Dermatol. 136, 1429\u20131437 (2016).","journal-title":"J. Investig. Dermatol."},{"key":"66601_CR61","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","volume":"125","author":"KD Stone","year":"2010","unstructured":"Stone, K. D., Prussin, C. & Metcalfe, D. D. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 125, S73\u2013S80. https:\/\/doi.org\/10.1016\/j.jaci.2009.11.017 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"66601_CR62","doi-asserted-by":"publisher","first-page":"AB36","DOI":"10.1016\/j.jaci.2011.12.796","volume":"129","author":"M Oh","year":"2012","unstructured":"Oh, M., Zhu, Z., Yu, J. & Zheng, T. Role of mast cells in the development of atopic dermatitis induced by IL-13. J. Allergy Clin. Immunol. 129, AB36. https:\/\/doi.org\/10.1016\/j.jaci.2011.12.796 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"66601_CR63","first-page":"97","volume":"16","author":"M Furue","year":"2019","unstructured":"Furue, M. et al. Pathogenesis of atopic dermatitis: Current paradigm. Iran. J. Immunol. 16, 97\u2013107 (2019).","journal-title":"Iran. J. Immunol."},{"key":"66601_CR64","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","volume":"147","author":"Y Renert-Yuval","year":"2021","unstructured":"Renert-Yuval, Y. et al. Biomarkers in atopic dermatitis\u2014A review on behalf of the International Eczema Council. J. Allergy Clin. Immunol. 147, 1174-1190.e1. https:\/\/doi.org\/10.1016\/j.jaci.2021.01.013 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"66601_CR65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/1346-8138.15664","volume":"48","author":"T Nakahara","year":"2021","unstructured":"Nakahara, T., Kido-Nakahara, M., Tsuji, G. & Furue, M. Basics and recent advances in the pathophysiology of atopic dermatitis. J. Dermatol. 48, 130\u2013139 (2021).","journal-title":"J. Dermatol."},{"key":"66601_CR66","first-page":"2509","volume":"23","author":"CH Ng","year":"2018","unstructured":"Ng, C. H. et al. Hits-to-lead optimization of the natural compound 2,4,6-trihydroxy-3-geranyl-acetophenone (tHGA) as a potent LOX inhibitor: Synthesis, structure-activity relationship (SAR) study, and computational assignment. Mol. J. Synth. Chem. Nat. Prod. Chem. 23, 2509 (2018).","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"key":"66601_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J. Basic Clin. Pharm."},{"key":"66601_CR68","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","volume":"9","author":"JD Bos","year":"2000","unstructured":"Bos, J. D. & Meinardi, M. M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9, 165\u2013169 (2000).","journal-title":"Exp. Dermatol."},{"key":"66601_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11095-007-9429-7","volume":"25","author":"C Herkenne","year":"2008","unstructured":"Herkenne, C. et al. In vivo methods for the assessment of topical drug bioavailability. Pharm. Res. 25, 87\u2013103 (2008).","journal-title":"Pharm. Res."},{"key":"66601_CR70","unstructured":"Price, G. & Patel, D. A. Drug Bioavailability. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557852\/ (StatPearls Publishing, 2023)."},{"key":"66601_CR71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1254\/jphs.09R01FM","volume":"110","author":"N Inagaki","year":"2009","unstructured":"Inagaki, N. & Nagai, H. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: Mouse models for the development of remedies for human allergic dermatitis. J. Pharmacol. Sci. 110, 251\u2013259 (2009).","journal-title":"J. Pharmacol. Sci."},{"key":"66601_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.785782","volume":"13","author":"VNK Mohd Kasim","year":"2022","unstructured":"Mohd Kasim, V. N. K. et al. Management of atopic dermatitis via oral and topical administration of herbs in murine model: A systematic review. Front. Pharmacol. 13, 785782. https:\/\/doi.org\/10.3389\/fphar.2022.785782 (2022).","journal-title":"Front. Pharmacol."},{"key":"66601_CR73","first-page":"389","volume":"90","author":"BC Martel","year":"2017","unstructured":"Martel, B. C., Lovato, P., B\u00e4umer, W. & Olivry, T. Translational animal models of atopic dermatitis for preclinical studies. Yale J. Biol. Med. 90, 389\u2013402 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"66601_CR74","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/exd.13498","volume":"27","author":"A L\u00f6wa","year":"2018","unstructured":"L\u00f6wa, A., Jevti\u0107, M., Gorreja, F. & Hedtrich, S. Alternatives to animal testing in basic and preclinical research of atopic dermatitis. Exp. Dermatol. 27, 476\u2013483 (2018).","journal-title":"Exp. Dermatol."},{"key":"66601_CR75","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1126\/science.327.5973.1571","volume":"327","author":"C Wald","year":"2010","unstructured":"Wald, C. & Wu, C. Biomedical research. Of mice and women: The bias in animal models. Science 327, 1571\u20131572 (2010).","journal-title":"Science"},{"key":"66601_CR76","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot, S. et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy 73, 1284\u20131293 (2018).","journal-title":"Allergy"},{"key":"66601_CR77","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ijwd.2021.10.002","volume":"7","author":"KL Tuttle","year":"2021","unstructured":"Tuttle, K. L., Forman, J. & Beck, L. A. Novel systemic treatments in atopic dermatitis: Are there sex differences?. Int. J. Womens Dermatol. 7, 606\u2013614 (2021).","journal-title":"Int. J. Womens Dermatol."},{"key":"66601_CR78","first-page":"19","volume":"26","author":"KL Hon","year":"2020","unstructured":"Hon, K. L. et al. Age, sex, and disease status as determinants of skin hydration and transepidermal water loss among children with and without eczema. Hong Kong Med. J. 26, 19\u201326 (2020).","journal-title":"Hong Kong Med. J."},{"key":"66601_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163560","volume":"11","author":"K Mukai","year":"2016","unstructured":"Mukai, K., Urai, T., Asano, K., Nakajima, Y. & Nakatani, T. Evaluation of effects of topical estradiol benzoate application on cutaneous wound healing in ovariectomized female mice. PLoS\u00a0One 11, e0163560. https:\/\/doi.org\/10.1371\/journal.pone.0163560 (2016).","journal-title":"PLoS\u00a0One"},{"key":"66601_CR80","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1523-1747.2001.01281.x","volume":"116","author":"JS Kao","year":"2001","unstructured":"Kao, J. S. et al. Testosterone perturbs epidermal permeability barrier homeostasis. J. Investig. Dermatol. 116, 443\u2013451 (2001).","journal-title":"J. Investig. Dermatol."}],"updated-by":[{"DOI":"10.1038\/s41598-024-73658-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66601-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T16:04:44Z","timestamp":1727798684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66601-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["66601"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-66601-0","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-024-73658-4","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-73658-4","URL":"https:\/\/doi.org\/10.1038\/s41598-024-73658-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17623"}}